Acute and chronic graft-versus-host disease (GVHD) continue to be major limitations to
successful hematopoietic stem cell transplantation. A variety of different immunosuppressive …

The aim of our study was to assess the efficacy of extracorporeal photopheresis (ECP) in
chronic graft-versus-host disease (GVHD). Eleven patients with chronic cutaneous GVHD …

Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

Background Extracorporeal photopheresis (ECP) has been shown as active therapy for graft‐
versus‐host disease (GVHD). Study Design and Methods The aim was to ascertain the role …

Abstract Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory
therapy developed for cutaneous T‐cell lymphoma, has shown promise in treating chronic …

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated with
extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive …

We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …

In a prior multicenter randomized controlled trial, we found that a 12-week course of
extracorporeal photopheresis (ECP) plus standard immunosuppressive therapy resulted in …

Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …